These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16973337)

  • 1. Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctors.
    Livermore DM; Reynolds R; Stephens P; Duckworth G; Felmingham D; Johnson AP; Murchan S; Murphy O; Gungabissoon U; Waight P; Pebody R; Shackcloth J; Warner M; Williams L; George RC
    Int J Antimicrob Agents; 2006 Oct; 28(4):273-9. PubMed ID: 16973337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal resistance in the UK.
    Goldsmith CE; Moore JE; Murphy PG
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():11-8. PubMed ID: 9484868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
    Rothermel CD
    Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.
    Bergman M; Huikko S; Huovinen P; Paakkari P; Seppälä H;
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3646-50. PubMed ID: 16940064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme.
    Reynolds R; Shackcloth J; Felmingham D; MacGowan A;
    J Antimicrob Chemother; 2003 Dec; 52(6):931-43. PubMed ID: 14585865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe.
    Bruinsma N; Kristinsson KG; Bronzwaer S; Schrijnemakers P; Degener J; Tiemersma E; Hryniewicz W; Monen J; Grundmann H;
    J Antimicrob Chemother; 2004 Dec; 54(6):1045-50. PubMed ID: 15531598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005.
    Karlowsky JA; Lagacé-Wiens PR; Low DE; Zhanel GG
    Int J Antimicrob Agents; 2009 Oct; 34(4):375-9. PubMed ID: 19560902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
    Farrell DJ; Jenkins SG
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A European study on the relationship between antimicrobial use and antimicrobial resistance.
    Bronzwaer SL; Cars O; Buchholz U; Mölstad S; Goettsch W; Veldhuijzen IK; Kool JL; Sprenger MJ; Degener JE;
    Emerg Infect Dis; 2002 Mar; 8(3):278-82. PubMed ID: 11927025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
    Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
    Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Streptococcus pneumoniae strains resistance to macrolide, lincosamide, streptogramin, oxazolidinone and ketolide].
    Sener B; Köseoğlu O; Fişenk I; Hasçelik G; Günalp A
    Mikrobiyol Bul; 2002 Apr; 36(2):125-31. PubMed ID: 12652863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?
    Livermore DM; Hope R; Reynolds R; Blackburn R; Johnson AP; Woodford N
    J Antimicrob Chemother; 2013 Nov; 68(11):2667-74. PubMed ID: 23766490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penicillin resistance in pneumococci.
    Felmingham D; Tesfaslasie Y; Burley C; Masterton RG
    J Antimicrob Chemother; 2000 May; 45(5):710-1. PubMed ID: 10797100
    [No Abstract]   [Full Text] [Related]  

  • 14. Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003.
    Johnson AP; Lamagni TL; Wale M; Cavendish S; Bishop L; Alhaddad N; Warner M; Livermore DM; Duckworth G; George RC
    Int J Antimicrob Agents; 2005 Jun; 25(6):539-41. PubMed ID: 15890501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic usage in Taiwan.
    Hsueh PR
    Clin Microbiol Infect; 2005 Nov; 11(11):925-7. PubMed ID: 16216110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the European Antimicrobial Resistance Surveillance System on the development of a national programme to monitor resistance in Staphylococcus aureus and Streptococcus pneumoniae in Ireland, 1999-2003.
    Murphy OM; Murchan S; Whyte D; Humphreys H; Rossney A; Clarke P; Cunney R; Keane C; Fenelon LE; O'Flanagan D
    Eur J Clin Microbiol Infect Dis; 2005 Jul; 24(7):480-3. PubMed ID: 15977004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
    Sunakawa K; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.
    Hicks LA; Chien YW; Taylor TH; Haber M; Klugman KP;
    Clin Infect Dis; 2011 Oct; 53(7):631-9. PubMed ID: 21890767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA).
    Mölstad S; Cars O
    Scand J Infect Dis; 1999; 31(2):191-5. PubMed ID: 10447331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.